| Company Name: |
BePharm Ltd
|
| Tel: |
400-685-9117 |
| Email: |
market@bepharm.com |
| Products Intro: |
Product Name:6,7-Dimethoxy-1-(4-methoxybenzyl)-1,2,3,4-tetrahydroisoquinoline
CAS:41498-37-7
Purity:98% Package:7990RMB/1g
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:GS 389;GS 389
CAS:41498-37-7
Purity:98% Package:5 mg
|
|
| Product Name: | GS 389 | | Synonyms: | GS 389;1,2,3,4-Tetrahydro-1-(4-methoxybenzyl)-6,7-dimethoxyisoquinoline;1,2,3,4-Tetrahydro-6,7-dimethoxy-1-(4-methoxybenzyl)isoquinoline;6,7-diMethoxy-1-(4-Methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-2-iuM chloride;6,7-Dimethoxy-1-(4-methoxybenzyl)-1,2,3,4-tetrahydroisoquinoline;HIGE-004;Isoquinoline, 1,2,3,4-tetrahydro-6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]- | | CAS: | 41498-37-7 | | MF: | C19H23NO3 | | MW: | 313.39 | | EINECS: | 1533716-785-6 | | Product Categories: | | | Mol File: | 41498-37-7.mol |  |
| | GS 389 Chemical Properties |
| Melting point | 200-203 °C | | Boiling point | 454.0±45.0 °C(Predicted) | | density | 1.108±0.06 g/cm3(Predicted) | | pka | 8.75±0.40(Predicted) |
| | GS 389 Usage And Synthesis |
| Description | GS 389 is a novel tetrahydroisoquinoline analog. GS-389 significantly increased cGMP levels in the rat aorta and inhibited cGMP phosphodiesterase from the rabbit brain. It has vasorelaxant properties. |
| | GS 389 Preparation Products And Raw materials |
|